These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8879436)

  • 1. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.
    Farish E; Spowart K; Barnes JF; Fletcher CD; Calder A; Brown A; Hart DM
    Atherosclerosis; 1996 Sep; 126(1):77-84. PubMed ID: 8879436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate.
    Owens D; Collins PB; Johnson A; Tomkin GH
    Diabet Med; 2000 Apr; 17(4):308-15. PubMed ID: 10821298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
    Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
    Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.
    Kotecha PT; Godsland IF; Crook D; Stevenson JC
    Clin Endocrinol (Oxf); 2020 Apr; 92(4):303-311. PubMed ID: 31925799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
    Nerbrand C; Nyberg P; Nordström L; Samsioe G
    Maturitas; 2002 May; 42(1):55-62. PubMed ID: 12020980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J;
    Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a new cyclical sequential postmenopausal HRT on lipoprotein, apoprotein and thrombophilia profile.
    Habiba M; Akkad A; al-Azzawi F
    Eur J Obstet Gynecol Reprod Biol; 1995 Sep; 62(1):89-94. PubMed ID: 7493716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
    Mc Manus J; Mc Eneny J; Thompson W; Young IS
    Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause.
    Griffin B; Farish E; Walsh D; Barnes J; Caslake M; Shepherd J; Hart D
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):463-8. PubMed ID: 8287573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term study of the effects of norethisterone on lipoprotein metabolism in menopausal women.
    Farish E; Fletcher CD; Hart DM; Kitchener H; Sharpe GL
    Clin Chim Acta; 1983 Aug; 132(2):193-8. PubMed ID: 6577991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of two continuous HRT regimens on cardiovascular risk factors.
    Barnes JF; Farish E; Rankin M; Hart DM
    Atherosclerosis; 2002 Jan; 160(1):185-93. PubMed ID: 11755937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.
    Sattar N; Greer IA; Louden J; Lindsay G; McConnell M; Shepherd J; Packard CJ
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on lipoproteins of Trisequens, a combined hormone preparation.
    Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
    Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
    Sendag F; Karadadas N; Ozsener S; Bilgin O
    Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
    Falkeborn M; Lithell H; Persson I; Vessby B; Naessén T
    Climacteric; 2002 Sep; 5(3):240-8. PubMed ID: 12419082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of continuous combined estrogen and desogestrel hormone replacement therapy on serum lipids and lipoproteins.
    Marsh MS; Crook D; Whitcroft SI; Worthington M; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Jan; 83(1):19-23. PubMed ID: 8272301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.